30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Oramed Pharmaceuticals Inc (ORMP)

Track

The most recent insider trading activity occurred on April 4, 2023. Insiders, including President and CEO KIDRON NADAV and others, have made several significant buy transactions in March and April 2023. Notably, a large sell transaction by Chief Scientific Officer Kidron Miriam also occurred in March 2023.
Stock chart
Ticker: ORMP Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Mayer Arie
1 purchase — total 8,398 USD
Buy 4 Apr 2023
Value US$265,151.98 | Price 428.67 | Shares 44,592
Buy 3 Apr 2023
Value US$3,243,411.89 | Price 225.33 | Shares 5,460
Buy 16 Mar 2023
Value US$53,014.00 | Price 2.04 | Shares 26,000
Sale 14 Mar 2023
Value US$201,000.00 | Price 2.01 | Shares 100,000
Buy 14 Mar 2023
Value US$201,000.00 | Price 2.01 | Shares 100,000
Buy 14 Mar 2023
Value US$102,450.00 | Price 2.05 | Shares 50,000
Buy 13 Mar 2023
Value US$39,120.00 | Price 1.96 | Shares 20,000
Planned sale 3 Jan 2023
Value US$148,651.23 | Price 12.49 | Shares 11,900
Planned sale 3 Jan 2023
Value US$18,543.81 | Price 13.01 | Shares 1,425
Sale 21 Mar 2022
Value US$94,096.00 | Price 9.41 | Shares 10,000
Sale 1 Nov 2021
Value US$76,800.00 | Price 25.60 | Shares 3,000
Planned sale 9 Aug 2021
Value US$4,423,144.00 | Price 20.11 | Shares 220,000
Buy 9 Sep 2019
Value US$29,500.00 | Price 2.95 | Shares 10,000
Buy 9 Sep 2019
Value US$43,500.00 | Price 2.90 | Shares 15,000
Buy 18 Jul 2019
Value US$17,335.94 | Price 3.86 | Shares 4,497
Buy 17 Jul 2019
Value US$37,496.84 | Price 3.74 | Shares 10,020
Buy 17 Jul 2019
Value US$71,562.00 | Price 3.58 | Shares 20,000
Buy 16 Jul 2019
Value US$69,316.00 | Price 3.47 | Shares 20,000
Buy 11 Jul 2019
Value US$4,250.40 | Price 3.22 | Shares 1,320
Buy 9 Aug 2018
Value US$9,960.00 | Price 4.98 | Shares 2,000
Buy 9 Aug 2018
Value US$2,410.00 | Price 4.82 | Shares 500
Buy 11 Jul 2018
Value US$722.18 | Price 5.92 | Shares 122
Sale 10 Jul 2018
Value US$364.97 | Price 5.98 | Shares 61
Sale 2 Aug 2017
Value US$761,906.00 | Price 8.50 | Shares 89,636
Buy 2 Aug 2017
Value US$761,906.00 | Price 8.50 | Shares 89,636
Buy 19 Apr 2017
Value US$334,312.62 | Price 6.33 | Shares 52,814
Sale 19 Apr 2017
Value US$334,312.62 | Price 6.33 | Shares 52,814
Buy 12 May 2016
Value US$710.00 | Price 7.10 | Shares 100
Buy 12 May 2016
Value US$2,100.00 | Price 7.00 | Shares 300
Buy 12 May 2016
Value US$2,073.00 | Price 6.91 | Shares 300
Buy 12 May 2016
Value US$2,070.00 | Price 6.90 | Shares 300
Sale 10 Mar 2016
Value US$54,842.00 | Price 6.45 | Shares 8,500
Sale 30 Dec 2015
Value US$206,707.20 | Price 8.61 | Shares 24,000
Sale 29 Dec 2015
Value US$136,177.50 | Price 9.08 | Shares 15,000
Sale 28 Dec 2015
Value US$101,915.00 | Price 9.27 | Shares 11,000
Sale 9 Dec 2015
Value US$6,608.00 | Price 9.44 | Shares 700
Sale 8 Dec 2015
Value US$6,620.70 | Price 8.70 | Shares 761
Sale 7 Dec 2015
Value US$4,689.30 | Price 8.70 | Shares 539
Buy 12 May 2015
Value US$664.00 | Price 6.64 | Shares 100
Buy 12 May 2015
Value US$1,326.00 | Price 6.63 | Shares 200
Buy 12 May 2015
Value US$662.00 | Price 6.62 | Shares 100
Buy 12 May 2015
Value US$1,310.00 | Price 6.55 | Shares 200
Buy 19 Mar 2015
Value US$400.00 | Price 4.00 | Shares 100
Buy 19 Mar 2015
Value US$4,312.00 | Price 3.92 | Shares 1,100
Buy 19 Mar 2015
Value US$1,580.00 | Price 3.95 | Shares 400
Buy 18 Mar 2015
Value US$1,900.00 | Price 3.80 | Shares 500
Buy 18 Mar 2015
Value US$1,890.00 | Price 3.78 | Shares 500
Sale 11 Sep 2014
Value US$73,401.29 | Price 8.44 | Shares 8,699
Sale 10 Sep 2014
Value US$193,259.80 | Price 8.40 | Shares 23,000
Sale 4 Sep 2014
Value US$78,111.58 | Price 9.41 | Shares 8,301
Buy 6 Jun 2014
Value US$9,998.88 | Price 4.44 | Shares 2,252
Buy 14 Apr 2014
Value US$10,087.00 | Price 14.41 | Shares 700
Sale 1 Apr 2014
Value US$1,651,581.70 | Price 12.03 | Shares 137,300
Sale 31 Mar 2014
Value US$99,057.00 | Price 10.50 | Shares 9,434
Buy 25 Mar 2014
Value US$515,551.08 | Price 10.90 | Shares 47,300
Buy 24 Mar 2014
Value US$281,257.49 | Price 10.15 | Shares 27,700
Buy 6 Feb 2014
Value US$400,941.40 | Price 14.96 | Shares 26,800
Buy 5 Feb 2014
Value US$399,797.61 | Price 16.32 | Shares 24,492
Sale 30 Dec 2013
Value US$12,510.00 | Price 15.00 | Shares 834
Buy 10 Jul 2013
Value US$49,034.15 | Price 7.40 | Shares 6,630
Buy 4 Oct 2011
Value US$300,000.00 | Price 0.32 | Shares 937,500
Sale 27 Sep 2011
Value US$98,000.00 | Price 0.28 | Shares 350,000
Buy 31 Mar 2011
Value US$250,000.00 | Price 0.32 | Shares 781,250
Buy 16 Jan 2008
Value US$1,250.00 | Price 0.25 | Shares 5,000
Buy 15 Jan 2008
Value US$3,912.50 | Price 0.25 | Shares 15,650
Buy 7 Jan 2008
Value US$6,852.00 | Price 0.30 | Shares 22,840
Buy 3 Jan 2008
Value US$14,400.00 | Price 0.30 | Shares 48,000
Buy 2 Jan 2008
Value US$35,948.17 | Price 0.30 | Shares 121,160
Buy 31 Dec 2007
Value US$20,247.00 | Price 0.24 | Shares 85,000
Buy 31 Dec 2007
Value US$2,500.00 | Price 0.25 | Shares 10,000
Sale 27 May 2004
Value US$19,800.00 | Price 0.00 | Shares 6,000,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-04-04 2023-04-04 B Purchase
4.0
Mayer Arie
Non-Executive Director
44,592 -41.5%
428.67
US$265,152 		44,592 -41.5% 428.67 US$265,152
2023-04-04 2023-04-03 B Purchase
4.0
Mayer Arie
Non-Executive Director
5,460 -7.2%
225.33
US$3,243,412 		5,460 -7.2% 225.33 US$3,243,412
2023-03-16 2023-03-16 B Purchase
3.6
KIDRON NADAV

President and CEO

Executive Director
61,357 +45.4%
69.17
US$2,847,208 		61,357 +45.4% 69.17 US$2,847,208
2023-03-15 2023-03-14 S Sale
0.5
Kidron Miriam

Chief Scientific Officer

Executive Director
100,000 -33.1%
2.01
US$201,000 		100,000 -33.1% 2.01 US$201,000
2023-03-15 2023-03-14 B Purchase
3.6
KIDRON NADAV

President and CEO

Executive Director
100,000 +inf%
2.01
US$201,000 		100,000 +inf% 2.01 US$201,000
2023-03-15 2023-03-14 B Purchase
4.1
Rozov Yadin
Non-Executive Director
50,000 +137.0%
2.05
US$102,450 		50,000 +137.0% 2.05 US$102,450
2023-03-15 2023-03-13 B Purchase
4.1
Rozov Yadin
Non-Executive Director
20,000 +121.2%
1.96
US$39,120 		20,000 +121.2% 1.96 US$39,120
2023-01-04 2023-01-03 PlS Planned sale
Rabinowitz Michael

Chief Commercial Officer

Officer
11,900 -8.6%
12.49
US$148,651 		11,900 -8.6% 12.49 US$148,651
2023-01-04 2023-01-03 PlS Planned sale
Rabinowitz Michael

Chief Commercial Officer

Officer
1,425 -1.0%
13.01
US$18,544 		1,425 -1.0% 13.01 US$18,544
2022-03-22 2022-03-21 S Sale
3.7
RAKIN KEVIN
Non-Executive Director
10,000 -17.6%
9.41
US$94,096 		10,000 -17.6% 9.41 US$94,096
2022-05-10 2021-11-01 S Sale
4.0
Mayer Arie
Non-Executive Director
3,000 -100.0%
25.60
US$76,800 		3,000 -100.0% 25.60 US$76,800
2021-08-11 2021-08-09 PlS Planned sale
3.6
KIDRON NADAV

President and CEO

Executive Director Large shareholder
220,000 -25.3%
20.11
US$4,423,144 		220,000 -25.3% 20.11 US$4,423,144
2019-09-11 2019-09-09 B Purchase
2.2
Sank Leonard
10,000 +2.7%
2.95
US$29,500 		10,000 +2.7% 2.95 US$29,500
2019-09-11 2019-09-09 B Purchase
2.2
Sank Leonard
15,000 +4.3%
2.90
US$43,500 		15,000 +4.3% 2.90 US$43,500
2019-07-18 2019-07-18 B Purchase
2.2
Sank Leonard
4,497 +1.3%
3.86
US$17,336 		4,497 +1.3% 3.86 US$17,336
2019-07-18 2019-07-17 B Purchase
2.2
Sank Leonard
10,020 +3.0%
3.74
US$37,497 		10,020 +3.0% 3.74 US$37,497
2019-07-18 2019-07-17 B Purchase
2.2
Sank Leonard
20,000 +6.3%
3.58
US$71,562 		20,000 +6.3% 3.58 US$71,562
2019-07-18 2019-07-16 B Purchase
2.2
Sank Leonard
20,000 +6.8%
3.47
US$69,316 		20,000 +6.8% 3.47 US$69,316
2019-07-15 2019-07-11 B Purchase
2.2
Sank Leonard
1,320 +0.4%
3.22
US$4,250 		1,320 +0.4% 3.22 US$4,250
2018-08-13 2018-08-09 B Purchase Friedman Aviad Non-Executive Director
2,000 +19.6%
4.98
US$9,960 		2,000 +19.6% 4.98 US$9,960
2018-08-13 2018-08-09 B Purchase Friedman Aviad Non-Executive Director
500 +5.2%
4.82
US$2,410 		500 +5.2% 4.82 US$2,410
2018-07-12 2018-07-11 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
122 +0.0%
5.92
US$722 		122 +0.0% 5.92 US$722
2018-07-12 2018-07-10 S Sale KIDRON NADAV

President and CEO

Executive Director Large shareholder
61 -0.0%
5.98
US$365 		61 -0.0% 5.98 US$365
2017-08-03 2017-08-02 S Sale Kidron Miriam

Chief Scientific Officer

Executive Director
89,636 -54.4%
8.50
US$761,906 		89,636 -54.4% 8.50 US$761,906
2017-08-03 2017-08-02 B Purchase Li Xiaopeng
89,636 +76.8%
8.50
US$761,906 		89,636 +76.8% 8.50 US$761,906
2017-04-19 2017-04-19 B Purchase Li Xiaopeng
52,814 +82.7%
6.33
US$334,313 		52,814 +82.7% 6.33 US$334,313
2017-04-19 2017-04-19 S Sale Kidron Miriam

Chief Scientific Officer

Executive Director
52,814 -37.1%
6.33
US$334,313 		52,814 -37.1% 6.33 US$334,313
2016-05-12 2016-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
100 +0.0%
7.10
US$710 		100 +0.0% 7.10 US$710
2016-05-12 2016-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
300 +0.0%
7.00
US$2,100 		300 +0.0% 7.00 US$2,100
2016-05-12 2016-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
300 +0.0%
6.91
US$2,073 		300 +0.0% 6.91 US$2,073
2016-05-12 2016-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
300 +0.0%
6.90
US$2,070 		300 +0.0% 6.90 US$2,070
2016-03-14 2016-03-10 S Sale JACOB HAROLD Non-Executive Director
8,500 -34.1%
6.45
US$54,842 		8,500 -34.1% 6.45 US$54,842
2015-12-31 2015-12-30 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
24,000 -14.4%
8.61
US$206,707 		24,000 -14.4% 8.61 US$206,707
2015-12-31 2015-12-29 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
15,000 -8.3%
9.08
US$136,178 		15,000 -8.3% 9.08 US$136,178
2015-12-31 2015-12-28 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
11,000 -5.7%
9.27
US$101,915 		11,000 -5.7% 9.27 US$101,915
2015-12-10 2015-12-09 S Sale Berelowitz Michael Non-Executive Director
700 -3.0%
9.44
US$6,608 		700 -3.0% 9.44 US$6,608
2015-12-09 2015-12-08 S Sale Berelowitz Michael Non-Executive Director
761 -3.1%
8.70
US$6,621 		761 -3.1% 8.70 US$6,621
2015-12-09 2015-12-07 S Sale Berelowitz Michael Non-Executive Director
539 -2.2%
8.70
US$4,689 		539 -2.2% 8.70 US$4,689
2015-05-12 2015-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
100 +0.0%
6.64
US$664 		100 +0.0% 6.64 US$664
2015-05-12 2015-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
200 +0.0%
6.63
US$1,326 		200 +0.0% 6.63 US$1,326
2015-05-12 2015-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
100 +0.0%
6.62
US$662 		100 +0.0% 6.62 US$662
2015-05-12 2015-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
200 +0.0%
6.55
US$1,310 		200 +0.0% 6.55 US$1,310
2015-03-20 2015-03-19 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
100 +0.0%
4.00
US$400 		100 +0.0% 4.00 US$400
2015-03-20 2015-03-19 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
1,100 +0.1%
3.92
US$4,312 		1,100 +0.1% 3.92 US$4,312
2015-03-20 2015-03-19 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
400 +0.0%
3.95
US$1,580 		400 +0.0% 3.95 US$1,580
2015-03-20 2015-03-18 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
500 +0.1%
3.80
US$1,900 		500 +0.1% 3.80 US$1,900
2015-03-20 2015-03-18 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
500 +0.1%
3.78
US$1,890 		500 +0.1% 3.78 US$1,890
2014-09-12 2014-09-11 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
8,699 -7.8%
8.44
US$73,401 		8,699 -7.8% 8.44 US$73,401
2014-09-12 2014-09-10 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
23,000 -17.1%
8.40
US$193,260 		23,000 -17.1% 8.40 US$193,260
2014-09-08 2014-09-04 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
8,301 -5.8%
9.41
US$78,112 		8,301 -5.8% 9.41 US$78,112
2014-06-10 2014-06-06 B Purchase REGALS CAPITAL MANAGEMENT LP Large shareholder
2,252 +0.2%
4.44
US$9,999 		2,252 +0.2% 4.44 US$9,999
2014-04-18 2014-04-14 B Purchase JACOB HAROLD Non-Executive Director
700 +inf%
14.41
US$10,087 		700 +inf% 14.41 US$10,087
2014-04-03 2014-04-01 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
137,300 -100.0%
12.03
US$1,651,582 		137,300 -100.0% 12.03 US$1,651,582
2014-04-02 2014-03-31 S Sale Berelowitz Michael Non-Executive Director
9,434 -100.0%
10.50
US$99,057 		9,434 -100.0% 10.50 US$99,057
2014-03-25 2014-03-25 B Purchase REGALS CAPITAL MANAGEMENT LP Large shareholder
47,300 +3.4%
10.90
US$515,551 		47,300 +3.4% 10.90 US$515,551
2014-03-25 2014-03-24 B Purchase REGALS CAPITAL MANAGEMENT LP Large shareholder
27,700 +2.0%
10.15
US$281,257 		27,700 +2.0% 10.15 US$281,257
2014-02-06 2014-02-06 B Purchase REGALS CAPITAL MANAGEMENT LP Large shareholder
26,800 +2.0%
14.96
US$400,941 		26,800 +2.0% 14.96 US$400,941
2014-02-06 2014-02-05 B Purchase REGALS CAPITAL MANAGEMENT LP Large shareholder
24,492 +1.8%
16.32
US$399,798 		24,492 +1.8% 16.32 US$399,798
2014-01-29 2013-12-30 S Sale JACOB HAROLD Non-Executive Director
834 -100.0%
15.00
US$12,510 		834 -100.0% 15.00 US$12,510
2013-07-12 2013-07-10 B Purchase REGALS CAPITAL MANAGEMENT LP Large shareholder
6,630 +0.5%
7.40
US$49,034 		6,630 +0.5% 7.40 US$49,034
2011-10-06 2011-10-04 B Purchase Sank Leonard Non-Executive Director
937,500 +inf%
0.32
US$300,000 		937,500 +inf% 0.32 US$300,000
2011-09-28 2011-09-27 S Sale Bronfeld Zeev Large shareholder
350,000 -5.7%
0.28
US$98,000 		350,000 -5.7% 0.28 US$98,000
2011-04-04 2011-03-31 B Purchase Bronfeld Zeev Large shareholder
781,250 +12.1%
0.32
US$250,000 		781,250 +12.1% 0.32 US$250,000
2008-01-17 2008-01-16 B Purchase Sank Leonard Non-Executive Director
5,000 +0.1%
0.25
US$1,250 		5,000 +0.1% 0.25 US$1,250
2008-01-17 2008-01-15 B Purchase Sank Leonard Non-Executive Director
15,650 +0.4%
0.25
US$3,912 		15,650 +0.4% 0.25 US$3,912
2008-01-09 2008-01-07 B Purchase Sank Leonard Non-Executive Director
22,840 +0.6%
0.30
US$6,852 		22,840 +0.6% 0.30 US$6,852
2008-01-07 2008-01-03 B Purchase Sank Leonard Non-Executive Director
48,000 +1.4%
0.30
US$14,400 		48,000 +1.4% 0.30 US$14,400
2008-01-03 2008-01-02 B Purchase Sank Leonard Non-Executive Director
121,160 +3.6%
0.30
US$35,948 		121,160 +3.6% 0.30 US$35,948
2008-01-03 2007-12-31 B Purchase Sank Leonard Non-Executive Director
85,000 +2.6%
0.24
US$20,247 		85,000 +2.6% 0.24 US$20,247
2008-01-03 2007-12-31 B Purchase Sank Leonard Non-Executive Director
10,000 +0.3%
0.25
US$2,500 		10,000 +0.3% 0.25 US$2,500
2004-06-10 2004-05-27 S Sale Young Michael

Fmr.Pres,CEO,Director,10%Owner
6,000,000 -100.0%
0.00
US$19,800 		6,000,000 -100.0% 0.00 US$19,800
Explore more

More insider trading research around Oramed Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America